Opioid Overdoses and Take-Home Naloxone Interventions: Ethnographic Evidence for Individual-Level Barriers to Treatment of Opioid Use Disorders in Rural Appalachia

被引:0
|
作者
Garcia, Victor [1 ]
McCann, Lisa [2 ]
Lauber, Erick [3 ]
Vaccaro, Christian [4 ,5 ]
Swauger, Melissa [6 ]
Heckert, Daniel Alex [4 ,7 ]
机构
[1] Prevent Res Ctr, 2030 Addison St Suite 410, Berkeley, CA 94704 USA
[2] Indiana Univ Penn, Dept Sociol, Indiana, PA USA
[3] Indiana Univ Penn, Dept Commun Media, Indiana, PA USA
[4] Indiana Univ Penn, Dept Sociol, Indiana, PA USA
[5] Indiana Univ Penn, Mid Atlantic Res & Training Inst, Indiana, PA USA
[6] Slippery Rock Univ Penn, Nonprofit Management Empowerment & Divers Studies, Slippery Rock, PA USA
[7] Indiana Univ Penn, Mid Atlantic Res & Training Ctr, Indiana, PA USA
关键词
Opioid overdose; naloxone; OUD treatment; OUD treatment barriers; rural Appalachia; CHALLENGES;
D O I
10.1080/10826084.2024.2340986
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction: Research indicates that take-home naloxone (THN) is saving lives across rural Appalachia, but whether it also results in treatment for opioid use disorders (OUDs) remains unclear. This study involves a detailed qualitative analysis of interviews with 16 individuals who had overdosed on opioids 61 times to understand why a THN intervention does not routinely lead to OUD treatment. Methods: This study builds upon a one-year (2018) qualitative study on community responses to opioid overdose fatalities in four adjacent rural counties in Western Pennsylvania. Using a semi-structured interview guide, 16 individuals who had experienced one or more overdoses were interviewed. Using NVivo, the transcribed audio-recorded interviews were coded, and a thematic analysis of the coded text was conducted. Findings: Findings reveal that of the 29 overdoses that included a THN intervention, only eight resulted in treatment. The analysis derives five individual-level barriers to treatment: (1) opioid dependence, (2) denial/readiness, (3) opioid withdrawal fears, (4) incarceration concerns, and (5) stigma and shame. These barriers impeded treatment, even though all the interviewees knew of treatment programs, how to access them, and in some cases had undergone treatment previously. Discussion and Conclusion: findings indicate that there is evidence that the five barriers make entering treatment after a THN intervention challenging and seemingly insurmountable at times. Recommendations based on the findings include increasing efforts to reduce stigma of OUDs in the community, including self-stigma resulting from misusing opioids, increasing informational efforts about Good Samaritan Laws, and increasing familiarity with medication-assisted treatments for OUDS.
引用
收藏
页码:1313 / 1322
页数:10
相关论文
共 19 条
  • [1] Take-home Naloxone at Opioid Treatment Programs: A Lifesaver
    Katzman, Joanna G.
    Bhatt, Snehal
    Comerci, George D. Jr Jr
    JOURNAL OF ADDICTION MEDICINE, 2022, 16 (06) : E417 - E419
  • [2] Association of Take-Home Naloxone and Opioid Overdose Reversals Performed by Patients in an Opioid Treatment Program
    Katzman, Joanna G.
    Takeda, Mikiko Y.
    Greenberg, Nina
    Moya Balasch, Monica
    Alchbli, Amal
    Katzman, William G.
    Salvador, Julie G.
    Bhatt, Snehal R.
    JAMA NETWORK OPEN, 2020, 3 (02)
  • [3] Barriers to and recommendations for take-home naloxone distribution: perspectives from opioid treatment programs in New Mexico
    Salvador, Julie G.
    Sussman, Andrew L.
    Takeda, Mikiko Y.
    Katzman, William G.
    Moya Balasch, Monica
    Katzman, Joanna G.
    HARM REDUCTION JOURNAL, 2020, 17 (01)
  • [4] Barriers to and recommendations for take-home naloxone distribution: perspectives from opioid treatment programs in New Mexico
    Julie G. Salvador
    Andrew L. Sussman
    Mikiko Y. Takeda
    William G. Katzman
    Monica Moya Balasch
    Joanna G. Katzman
    Harm Reduction Journal, 17
  • [5] Should we worry that take-home naloxone availability may increase opioid use?
    Tas, Basak
    Humphreys, Keith
    McDonald, Rebecca
    Strang, John
    ADDICTION, 2019, 114 (10) : 1723 - 1725
  • [6] Access and Barriers to Take-Home Naloxone Use among Emergency Department Patients with Opioid Misuse in Baltimore, Maryland, USA
    Hurt, Brenten R.
    Hussain, Atizaz
    Aledhaim, Ali
    Moayedi, Siamak
    Schenkel, Stephen M.
    Kim, Hong K.
    SUBSTANCE USE & MISUSE, 2020, 55 (13) : 2237 - 2242
  • [7] Take-home naloxone treatment for opioid emergencies: a comparison of routes of administration and associated delivery systems
    Elzey, Mark J.
    Fudin, Jeffrey
    Edwards, Eric S.
    EXPERT OPINION ON DRUG DELIVERY, 2017, 14 (09) : 1045 - 1058
  • [8] Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment
    Luo, Sean X.
    Feaster, Daniel J.
    Liu, Ying
    Balise, Raymond R.
    Hu, Mei-Chen
    Bouzoubaa, Layla
    Odom, Gabriel J.
    Brandt, Laura
    Pan, Yue
    Hser, Yih-Ing
    VanVeldhuisen, Paul
    Castillo, Felipe
    Calderon, Anna R.
    Rotrosen, John
    Saxon, Andrew J.
    Weiss, Roger D.
    Wall, Melanie
    Nunes, Edward V.
    JAMA PSYCHIATRY, 2024, 81 (01) : 45 - 56
  • [9] Cost-effectiveness of flexible take-home buprenorphine-naloxone versus methadone for treatment of prescription-type opioid use disorder
    Enns, Benjamin
    Krebs, Emanuel
    Whitehurst, David G. T.
    Jutras-Aswad, Didier
    Le Foll, Bernard
    Socias, M. Eugenia
    Nosyk, Bohdan
    DRUG AND ALCOHOL DEPENDENCE, 2023, 247
  • [10] The effects of a novel take-home treatment strategy in patients with opioid-dependence receiving long-term opioid replacement therapy with buprenorphine/naloxone in Italy: a cost analysis
    Montesano, Franco
    Mellace, Vincenzo
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2013, 15 (01) : 45 - 51